Literature DB >> 5254302

A screening method for liver glycogen diseases.

J Fernandes, F Huijing, J H van de Kamer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5254302      PMCID： PMC2020319          DOI： 10.1136/adc.44.235.311

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  11 in total

1.  AMYLO-1,6-GLUCOSIDASE ACTIVITY IN NORMAL LEUCOCYTES AND IN LEUCOCYTES OF PATIENTS WITH GLYCOGEN-STORAGE DISEASE.

Authors:  F HUIJING
Journal:  Clin Chim Acta       Date:  1964-03       Impact factor: 3.786

2.  STUDIES ON THE UTILIZATION OF HEXOSES IN LIVER GLYCOGEN DISEASE.

Authors:  J FERNANDES; J H VAN DE KAMER
Journal:  Pediatrics       Date:  1965-03       Impact factor: 7.124

3.  GLYCOGEN STORAGE DISEASE. BIOCHEMICAL AND CLINICAL DATA IN SIXTEEN CASES.

Authors:  F HUIJING
Journal:  Am J Med       Date:  1965-04       Impact factor: 4.965

4.  Lactate metabolism. Studies of a child with a serious congenital deviation.

Authors:  A F HARTMANN; H J WOHLTMANN; M L PURKERSON; M E WESLEY
Journal:  J Pediatr       Date:  1962-08       Impact factor: 4.406

5.  Glucagon tolerance test in glycogen storage disease.

Authors:  G HUG
Journal:  J Pediatr       Date:  1962-04       Impact factor: 4.406

6.  Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.

Authors:  R R HOWELL; D M ASHTON; J B WYNGAARDEN
Journal:  Pediatrics       Date:  1962-04       Impact factor: 7.124

7.  Galactose tolerance in glycogen storage disease.

Authors:  R SCHWARTZ; J ASHMORE; A E RENOLD
Journal:  Pediatrics       Date:  1957-04       Impact factor: 7.124

8.  Studies in liver glycogen disease. Effects of glucagon and other agents on metabolic pattern and clinical status.

Authors:  C U LOWE; J E SOKAL; L L MOSOVICH; E J SARCIONE; B H DORAY
Journal:  Am J Med       Date:  1962-07       Impact factor: 4.965

9.  The diagnosis of glycogen storage disease in clinical practice.

Authors:  P A Ockerman
Journal:  Isr J Med Sci       Date:  1967 May-Jun

10.  The activity of the debranching-enzyme system in leucocytes. A genetic study of glycogen storage disease type 3.

Authors:  F Huijing; H J Obbink; S Van Creveld
Journal:  Acta Genet Stat Med       Date:  1968
View more
  12 in total

1.  The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.

Authors:  P J Willems; W J Gerver; R Berger; J Fernandes
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

2.  Hepatic phosphorylase deficiency. Its differentiation from other hepatic glycogenoses.

Authors:  J Fernandes; J F Koster; W F Grose; N Sorgedrager
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

3.  Hepatic glycogen synthetase deficiency. Further studies on a family.

Authors:  J R Dykes; J Spencer-Peet
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

4.  Hepatic glycogen synthetase deficiency.

Authors: 
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

5.  Phosphorylase kinase deficiency.

Authors:  F Huijing
Journal:  Biochem Genet       Date:  1970-02       Impact factor: 1.890

6.  Glycogen storage disease (type I) presenting in the neonatal period.

Authors:  B R Hufton; B A Wharton
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

Review 7.  The glycogen storage diseases.

Authors:  B E Ryman
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

8.  Hepatic ultrastructure in leprechaunism. Hepatic ultrastructural evidence suggesting a syndrome with defective hepatic glucose release.

Authors:  S I Roth; H K Schedewie; D M Bier; H H Conaway; J Olefsky; A Rubenstein; M J Elders
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 9.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

10.  Hypoalaninemia: a concomitant of ketotic hypoglycemia.

Authors:  A S Pagliara; I E Kari; D C De Vivo; R D Feigin; D M Kipnis
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.